News
11h
Zacks Investment Research on MSNFDA Accepts Merck's Filing for Two-Drug, Once-Daily HIV PillMerck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...
2d
TipRanks on MSNMetaVia doses first patient in 48 mg MAD cohort of its Phase 1 trialMetaVia (MTVA) announced dosing of the first patient in the 48 mg, multiple ascending dose, MAD, cohort of its Phase 1 clinical trial of DA-1726, ...
Ativan, also known by its generic name lorazepam, is a prescription medication commonly used to treat anxiety disorder, insomnia, and seizures. If you or a family member has been prescribed […] ...
An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results